The Global Bioreactors and Fermenters Market is anticipated to grow at an annualized rate of ~11% by 2035, claims Roots Analysis

The COVID-19 pandemic has highlighted the imperative need for advanced bioreactors and fermenters for the production of biopharmaceuticals, precision medicine, and vaccines. Stakeholders have been actively engaged in developing biomanufacturing equipment with advanced features, including built-in sensors, controllers, and automated systems. The COVID-19 pandemic has highlighted the imperative need for advanced bioreactors and fermenters for the production of biopharmaceuticals, precision...

The COVID-19 pandemic has highlighted the imperative need for advanced bioreactors and fermenters for the production of biopharmaceuticals, precision medicine, and vaccines. Stakeholders have been actively engaged in developing biomanufacturing equipment with advanced features, including built-in sensors, controllers, and automated systems.

To order this 250+ page report, which features 90+ figures and 130+ tables, please visit 

https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html

Key Market Insights

Presently, more than 255 players claim to manufacture bioreactors and fermenters

This segment of the industry is dominated by the presence of start-ups / small companies (up to 50 employees) and mid-sized companies (51-500 employees), which collectively represent over 90% of the total number of players in this domain. In addition, nearly 50% of the firms engaged in this domain are based in Asia-Pacific.

Over 130 players currently manufacture bioreactors and fermenters intended for use across various scales, from preclinical research to commercial production

Further, over 10% of the firms can manufacture equipment with 3D cell culturing capability. In addition, close to 80% firms manufacture bioreactors and fermenters for batch bioprocesses, followed by players manufacturing continuous biomanufacturing equipment.

The installed bioreactors and fermenters are estimated to have the capacity of manufacturing 12.5 million liters of biologics, globally

At present, the major proportion (close to 65%) of this capacity is installed at facilities of in-house biologics manufacturers. Further, nearly 70% of the overall bioreactors and fermenters capacity is installed at the facilities based in North America and Europe.

North America and Europe are anticipated to capture around 70% share of the market, in 2035

The current market is driven by the revenues generated by sales of bioreactors and fermenters used for manufacturing antibodies (close to 40%); this trend is unlikely to change in the foreseen future. Further, majority share (~80%) of the overall market in 2035 is likely to be captured by bioreactors and fermenters supporting batch and fed-batch bioprocesses.

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market/request-sample.html

Key Questions Answered

The financial opportunity within the global bioreactors and fermenters market has been analyzed across the following segments:

The report also includes profiles of key players (listed below) engaged in manufacturing bioreactors and fermenters; each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.

For additional details, please visit 

https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html

You may also be interested in the following titles:

Contact:

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]  

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/the-global-bioreactors-and-fermenters-market-is-anticipated-to-grow-at-an-annualized-rate-of-11-by-2035-claims-roots-analysis-301913294.html